SC Administer once daily into lower abdominal wall at 24-hr intervals, either morning or evening. Administration in the morning: Commence on day 5 or 6 of ovarian stimulation (approx 96-120 hr after start of ovarian stimulation) w/ urinary or recombinant gonadotropins. Continue throughout gonadotropin treatment period including day of ovulation induction. Administration in the evening: Commence on day 5 of ovarian stimulation (approx 96-108 hr after start of ovarian stimulation) w/ urinary or recombinant gonadotropins. Continue throughout gonadotropin treatment period until the evening prior to day of ovulation induction.
Hypersensitivity to cetrorelix acetate or any structural analogues of gonadotropin-releasing hormones, extrinsic peptide hormones. Severe renal impairment. Pregnancy & lactation.
Not to be used in women w/ allergic condition or known history of allergic predisposition. Mild to moderate ovarian hyperstimulation syndrome (OHSS). Administration during repeated ovarian stimulation procedure. Hepatic & renal impairment. Not to be used during pregnancy & lactation. Congenital anomalies.
Sign Out
